F. ÖZDEMİR Et Al. , "Towards Novel Anti-tumor Strategies for Hepatic Cancer: epsilon-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells," OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , no.5, pp.324-334, 2014
ÖZDEMİR, F. Et Al. 2014. Towards Novel Anti-tumor Strategies for Hepatic Cancer: epsilon-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , no.5 , 324-334.
ÖZDEMİR, F., AKALIN ÇİFTÇİ, G., Sen, M., Onder, N. I., Iscan, A., KUTLU, H. M., ... Incesu, Z.(2014). Towards Novel Anti-tumor Strategies for Hepatic Cancer: epsilon-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , no.5, 324-334.
ÖZDEMİR, FİLİZ Et Al. "Towards Novel Anti-tumor Strategies for Hepatic Cancer: epsilon-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells," OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , no.5, 324-334, 2014
ÖZDEMİR, FİLİZ Et Al. "Towards Novel Anti-tumor Strategies for Hepatic Cancer: epsilon-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells." OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , no.5, pp.324-334, 2014
ÖZDEMİR, F. Et Al. (2014) . "Towards Novel Anti-tumor Strategies for Hepatic Cancer: epsilon-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells." OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , no.5, pp.324-334.
@article{article, author={FİLİZ ÖZDEMİR Et Al. }, title={Towards Novel Anti-tumor Strategies for Hepatic Cancer: epsilon-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells}, journal={OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY}, year=2014, pages={324-334} }